Description
Obrenza 150 Tablet 60’s is a specialized medication designed for the treatment of chronic myeloid leukemia (CML). Each tablet contains 150mg of Imatinib, a potent tyrosine kinase inhibitor that targets the BCR-ABL protein, a key driver in CML. This medication is taken orally and is a crucial component of CML management, helping to control the progression of the disease and improve patient outcomes. Obrenza offers hope for those living with CML, providing a targeted therapy that can help extend life and improve quality of life. Consult with your healthcare provider to determine if Obrenza is right for you.
Reviews
There are no reviews yet.